WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 462420
Description: CAIX Inhibitor S4 is an inhibitor of carbonic anhydrase IX. It is selective for CAIX over CAI and CAII but does inhibit CAXII. It reduced the number of lung metastases, but not primary tumor growth, in an MDA-MB-231 mouse xenograft model.
MedKoo Cat#: 462420
Name: CAIX Inhibitor S4
Chemical Formula: C15H17N3O4S
Exact Mass: 335.094
Molecular Weight: 335.378
Elemental Analysis: C, 53.72; H, 5.11; N, 12.53; O, 19.08; S, 9.56
Synonym: CAIX Inhibitor S4
IUPAC/Chemical Name: 4-(3-(3,5-dimethylphenyl)ureido)phenyl sulfamate
InChi Key: HGVHSNXRZYOTPD-UHFFFAOYSA-N
InChi Code: InChI=1S/C15H17N3O4S/c1-10-7-11(2)9-13(8-10)18-15(19)17-12-3-5-14(6-4-12)22-23(16,20)21/h3-9H,1-2H3,(H2,16,20,21)(H2,17,18,19)
SMILES Code: O=S(OC=CC=C(NC(NC=CC(C)=CC(C)=C@16)=O)C=C@6)(N)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 335.378 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Gieling, R.G., Babur, M., Mamnani, L., et al. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. J. Med. Chem. 55(11), 5591-5600 (2012).